Human SUMF2 activation kit by CRISPRa

CAT#: GA108595

SUMF2 CRISPRa kit - CRISPR gene activation of human sulfatase modifying factor 2



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (2)
SUMF2 Rabbit polyclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00


SUMF2 (Myc-DDK-tagged)-Human sulfatase modifying factor 2 (SUMF2), transcript variant 5
    • 10 ug

CNY 3656.00
CNY 3990.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol SUMF2
Locus ID 25870
Kit Components

GA108595G1, SUMF2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA108595G2, SUMF2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA108595G3, SUMF2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_001042468, NM_001042469, NM_001042470, NM_001130069, NM_001130070, NM_001146333, NM_015411, NM_001366647, NM_001366648, NM_001366649
Synonyms DKFZp566I1024; DKFZp686I1024; DKFZp686L17160; DKFZp781L1035; MGC99485; pFGE
Summary The catalytic sites of sulfatases are only active if they contain a unique amino acid, C-alpha-formylglycine (FGly). The FGly residue is posttranslationally generated from a cysteine by enzymes with FGly-generating activity. The gene described in this record is a member of the sulfatase-modifying factor family and encodes a protein with a DUF323 domain that localizes to the lumen of the endoplasmic reticulum. This protein has low levels of FGly-generating activity but can heterodimerize with another family member - a protein with high levels of FGly-generating activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...